##gff-version 3
##sequence-region Q86YS7 1 1000
Q86YS7	UniProtKB	Chain	1	1000	.	.	.	ID=PRO_0000247450;Note=C2 domain-containing protein 5	
Q86YS7	UniProtKB	Domain	1	90	.	.	.	Note=C2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00041	
Q86YS7	UniProtKB	Calcium binding	13	27	.	.	.	Note=1%3B low affinity	
Q86YS7	UniProtKB	Calcium binding	75	86	.	.	.	Note=2%3B high affinity	
Q86YS7	UniProtKB	Modified residue	197	197	.	.	.	Note=Phosphoserine%3B by PKB/AKT2;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Modified residue	200	200	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Modified residue	260	260	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YS7	UniProtKB	Modified residue	293	293	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:21406692;Dbxref=PMID:21406692	
Q86YS7	UniProtKB	Modified residue	295	295	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:20068231,PMID:21406692,PMID:23186163	
Q86YS7	UniProtKB	Modified residue	304	304	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPS5	
Q86YS7	UniProtKB	Modified residue	305	305	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YS7	UniProtKB	Modified residue	306	306	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPS5	
Q86YS7	UniProtKB	Modified residue	317	317	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:19369195;Dbxref=PMID:19369195	
Q86YS7	UniProtKB	Modified residue	323	323	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YS7	UniProtKB	Modified residue	601	601	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18691976;Dbxref=PMID:18691976	
Q86YS7	UniProtKB	Modified residue	643	643	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:19690332;Dbxref=PMID:18220336,PMID:18669648,PMID:18691976,PMID:19369195,PMID:19690332	
Q86YS7	UniProtKB	Modified residue	657	657	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPS5	
Q86YS7	UniProtKB	Modified residue	659	659	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:19690332,PMID:23186163	
Q86YS7	UniProtKB	Modified residue	661	661	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPS5	
Q86YS7	UniProtKB	Modified residue	662	662	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YS7	UniProtKB	Modified residue	666	666	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q86YS7	UniProtKB	Modified residue	671	671	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q86YS7	UniProtKB	Modified residue	807	807	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:23186163;Dbxref=PMID:23186163	
Q86YS7	UniProtKB	Modified residue	817	817	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q7TPS5	
Q86YS7	UniProtKB	Modified residue	852	852	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:18691976,ECO:0000244|PubMed:19369195,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:18691976,PMID:19369195,PMID:21406692,PMID:23186163	
Q86YS7	UniProtKB	Alternative sequence	268	316	.	.	.	ID=VSP_028255;Note=In isoform 2%2C isoform 4 and isoform 5. IPFNEDPNPNTHSSGPSTPLKNQTYSFSPSKSYSRQSSSSDTDLSLTPK->SPLVHPPSHGCRSTHNSPIHTATGSRLTQNFSVSVPTLIY;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q86YS7	UniProtKB	Alternative sequence	345	345	.	.	.	ID=VSP_055638;Note=In isoform 4. Q->QRGGSPHRFCRR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q86YS7	UniProtKB	Alternative sequence	382	382	.	.	.	ID=VSP_055639;Note=In isoform 5. P->PAFVGIMGNTRSYKLLDWNSFNS;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q86YS7	UniProtKB	Alternative sequence	845	845	.	.	.	ID=VSP_028256;Note=In isoform 2%2C isoform 3 and isoform 4. A->EHLESASSNSGIPAAQRATSVDYSSFADRCSSWIELIKLKAQTIRRGSIKTT;Ontology_term=ECO:0000303,ECO:0000303;evidence=ECO:0000303|PubMed:14702039,ECO:0000303|PubMed:15489334;Dbxref=PMID:14702039,PMID:15489334	
Q86YS7	UniProtKB	Alternative sequence	845	845	.	.	.	ID=VSP_055640;Note=In isoform 5. A->EHLESASSNSGIPAAQRDRCSSWIELIKLKAQTIRRGSIKTT;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q86YS7	UniProtKB	Mutagenesis	19	19	.	.	.	Note=Reduces calcium-binding%2C phospholipid membrane-binding and insulin-stimulated SLC2A4/GLUT4 translocation%3B when associated with A-26%3B A-76%3B A-78 and A-84. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	26	26	.	.	.	Note=Reduces calcium-binding%2C phospholipid membrane-binding and insulin-stimulated SLC2A4/GLUT4 translocation%3B when associated with A-19%3B A-76%3B A-78 and A-84. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	76	76	.	.	.	Note=Reduces calcium-binding%2C phospholipid membrane-binding and insulin-stimulated SLC2A4/GLUT4 translocation%3B when associated with A-19%3B A-26%3B A-78 and A-84. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	78	78	.	.	.	Note=Reduces calcium-binding%2C phospholipid membrane-binding and insulin-stimulated SLC2A4/GLUT4 translocation%3B when associated with A-19%3B A-26%3B A-76 and A-84. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	84	84	.	.	.	Note=Reduces calcium-binding%2C phospholipid membrane-binding and insulin-stimulated SLC2A4/GLUT4 translocation%3B when associated with A-19%3B A-26%3B A-76 and A-78. D->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	197	197	.	.	.	Note=Inhibits insulin-stimulated AKT2-induced phosphorylation%2C SLC2A4/GLUT4 translocation to the cell surface and GSV-PM fusion. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Mutagenesis	200	200	.	.	.	Note=Does not inhibit insulin-stimulated SLC2A4/GLUT4 translocation. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21907143;Dbxref=PMID:21907143	
Q86YS7	UniProtKB	Sequence conflict	997	997	.	.	.	Note=E->G;Ontology_term=ECO:0000305;evidence=ECO:0000305	
